Determinazione di profili autoanticorpali con metodi multiparametrici proteomici: impatto su prevenzione, diagnosi, monitoraggio e terapia personalizzata nelle malattie autoimmuni

The recent development of multiparametric proteomic assay able to detect many autoantibodies in a single run might replace conventional immunoassays, allowing for a more efficient handling of large numbers of samples by the laboratory, while ensuring greater diagnostic sensitivity in the screening and better management of autoimmune diseases. In the near future, the introduction of multiparametric autoantibody proteomic technology will likely have a major impact on the diagnosis, monitoring, and therapy of autoimmune disease. Extended disease-specific autoantibody profiles consisting of dozens, if not hundreds of autoantibodies will be able to define each patient’s autoantibody fingerprint and identify clinical phenotypes of patients with different prognostic characteristics and different therapeutic responses. In this review, we analyze the application and the potential of autoantibody profiles performed by proteomic multiplex immunoassays and the implications for personalized medicine.